Hippocampal sclerosis of ageing is a prevalent brain disease that afflicts older persons and has been linked with cerebrovascular pathology. Arteriolosclerosis is a subtype of cerebrovascular pathology characterized by concentrically thickened arterioles. Here we report data from multiple large autopsy series (University of Kentucky Alzheimer's Disease Centre, Nun Study, and National Alzheimer's Coordinating Centre) showing a specific association between hippocampal sclerosis of ageing pathology and arteriolosclerosis. The present analyses incorporate 226 cases of autopsy-proven hippocampal sclerosis of ageing and 1792 controls. Case-control comparisons were performed including digital pathological assessments for detailed analyses of blood vessel morphology. We found no evidence of associations between hippocampal sclerosis of ageing pathology and lacunar infarcts, large infarcts, Circle of Willis atherosclerosis, or cerebral amyloid angiopathy. Individuals with hippocampal sclerosis of ageing pathology did not show increased rates of clinically documented hypertension, diabetes, or other cardiac risk factors. The correlation between arteriolosclerosis and hippocampal sclerosis of ageing pathology was strong in multiple brain regions outside of the hippocampus. For example, the presence of arteriolosclerosis in the frontal cortex (Brodmann area 9) was strongly associated with hippocampal sclerosis of ageing pathology (P 5 0.001). This enables informative evaluation of anatomical regions outside of the hippocampus. To assess the morphology of brain microvasculature far more rigorously than what is possible using semi-quantitative pathological scoring, we applied digital pathological (Aperio ScanScope) methods on a subsample of frontal cortex sections from hippocampal sclerosis of ageing (n = 15) and control (n = 42) cases. Following technical studies to optimize immunostaining methods for small blood vessel visualization, our analyses focused on sections immunostained for smooth muscle actin (a marker of arterioles) and CD34 (an endothelial marker), with separate analyses on grey and white matter. A total of 43 834 smooth muscle actin-positive vascular profiles and 603 798 CD34-positive vascular profiles were evaluated. In frontal cortex of cases with hippocampal sclerosis of ageing, smooth muscle actin-immunoreactive arterioles had thicker walls (P 5 0.05), larger perimeters (P 5 0.03), and larger vessel areas (P 5 0.03) than controls. Unlike the arterioles, CD34-immunoreactive capillaries had dimensions that were unchanged in cases with hippocampal sclerosis of ageing versus controls. Arteriolosclerosis appears specific to hippocampal sclerosis of ageing brains, because brains with Alzheimer's disease pathology did not show the same morphological alterations. We conclude that there may be a pathogenetic change in aged human brain arterioles that impacts multiple brain areas and contributes to hippocampal sclerosis of ageing.
Introduction
Hippocampal sclerosis of ageing (HS-Ageing) is a poorly-understood brain disease with an enormous impact on public health. Currently the disease is defined by pathology: HS-Ageing is characterized by cell loss, gliosis and atrophy in the hippocampal formation that is out of proportion with Alzheimer's disease pathology in the same structures (Jellinger, 1994; Amador-Ortiz and Dickson, 2008; Nelson et al., 2011; Montine et al., 2012; Zarow et al., 2012) . Here we apply the definition of 'hippocampal formation' to include the subiculum (Amaral and Lavenex, 2007) , which is often severely affected in HS-Ageing. Hippocampal sclerosis pathology can be associated with different underlying causes, and the term 'HS-Ageing' refers to a specific subset with advanced age (Nelson et al., 2011 (Nelson et al., , 2013 . Even when co-morbid brain pathologies are taken into account, the presence of HS-Ageing pathology at autopsy correlates independently with substantial cognitive impairment (Kuslansky et al., 2004; Nelson et al., 2010 Nelson et al., , 2011 . HS-Ageing pathology is especially prevalent in brains of the 'oldest old', affecting $10-30% of individuals over the age of 85 years (Leverenz and Lipton, 2008; Nelson et al., 2011 Nelson et al., , 2013 Corrada et al., 2012) .
The molecular pathogenesis of HS-Ageing is not well understood (Nelson et al., 2013) . One aetiological mechanism that may cause or worsen HS-Ageing pathology is cerebrovascular disease (Dickson et al., 1994; Zarow et al., 2008) . Impairment of blood supply to the brain with reperfusion can cause death of hippocampal neurons, although this pathology is not immunopositive for aberrant TAR-DNA binding protein 43 (TDP-43) pathology (Neumann et al., 2006) , as cases with HS-Ageing tend to be (Amador-Ortiz et al., 2007; Lee et al., 2008; Nelson et al., 2011) . Further, some degree of cerebrovascular pathology is near-universal in individuals 490 years of age (Garde et al., 2000; Polvikoski et al., 2010; Nelson et al., 2011) . However, we previously found no strong and specific correlation between large-vessel cerebrovascular pathology and HS-Ageing pathology after age adjustment in the largest HS-Ageing autopsy series to date (Nelson et al., 2011) . A more complete assessment of cerebrovascular pathology would involve additional data sets along with a rigorous assessment of small vessel pathologies.
Here we analysed data drawn from multiple autopsy series to test rigorously the association between cerebrovascular pathology and HS-Ageing. We report a strong tendency for pathologically confirmed arteriolosclerosis to be associated with HS-Ageing pathology in the University of Kentucky Alzheimer's Disease Centre (UK-ADC) autopsy series, and this finding was confirmed in two additional autopsy series drawn from the National Alzheimer's Coordinating Centre (NACC) and the Nun Study. Arteriolosclerosis is a subtype of cerebrovascular pathology characterized by concentrically thickened and/or dysmorphic small blood vessels, particularly arterioles. Because the operational definition of arteriolosclerosis is vague, we applied digital pathological methods for rigorous assessment of small vessel histomorphology in a subsample of UK-ADC cases. We found that neither nonarteriolosclerosis cerebrovascular pathology subtypes nor cardiovascular risk factors appear to be associated with HS-Ageing pathology (as arteriolosclerosis is), which may indicate a specific role of arteriolosclerosis in HS-Ageing.
Materials and methods
Research volunteers who had come to autopsy from UK-ADC (n = 327) (Nelson et al., 2007; Schmitt et al., 2012) , NACC neuropathology data set excluding UK-ADC cases (n = 1444) (Beekly et al., 2004 (Beekly et al., , 2007 , and Nun Study (n = 247) (Snowdon et al., 1996; Wolf et al., 1999; Riley et al., 2002; Mortimer, 2012) cohorts were the basis for the study. All assessments were performed with institutional review board approval from their respective institutions. Clinicians and study staff lacked knowledge about the character or severity of pathology in the regions studied, minimizing bias in terms of case selection that would have affected our main outcome measures. All included subjects were at least 80 years old at death and were free from Parkinson's disease, autopsy-determined prion disease, triplet repeat diseases, brain cancer, frontotemporal lobar degeneration (FTLD), genetic or chromosomal abnormalities, or another neurological disease that might explain a dementia syndrome.
Among UK-ADC cases, all autopsied subjects with detailed quantitative neuropathological data were initially considered for inclusion (n = 660). Cases younger than 80 years at the time of death (n = 208), missing global ratings of arteriolosclerosis (n = 100) or over 80 years at death with any of the pathologies indicated above (n = 25) were excluded. Global ratings of arteriolosclerosis were missing for a portion of the sample: 9/48 (18.8%) cases with HS-Ageing and 91/379 (24.0%) cases without HS-Ageing pathology. These cases were excluded leaving 39 cases with HS-Ageing and 288 cases without HS-Ageing. For more information about cases missing arteriolosclerosis ratings both with and without HS-Ageing pathology, see Supplementary Table 1. Neuropathological evaluations were as described previously (Nelson et al., 2009) . For both the UK-ADC and NACC cohorts, semi-quantitative global neuropathological assessments of arteriolosclerosis were performed on a four-tier categorization system from the NACC Neuropathology Data Element Dictionary (v9.1) addressing the following coded question: 'Is arteriolosclerosis (small parenchymal arteriolar disease) present?', with responses (scored as 0-3) to designate 'none', 'mild', 'moderate' or 'severe', respectively. Additional cerebrovascular pathology measures in the UK-ADC cohort included infarct counts, semi-quantitative ratings of atherosclerosis, cerebral amyloid angiopathy, micro-infarcts, lacunar infarcts, pale infarcts and cortical laminar necrosis as previously described (White et al., 2002; Nelson et al., 2007 Nelson et al., , 2010 , as well as region-specific indicators for the presence or absence of arteriolosclerosis.
The Nun Study is a longitudinal study of participants from seven regions in the USA. Cases initially included in the current study (n = 526) had available neuropathological data as worked up at the UK-ADC. Exclusion criteria for the Nun Study cases were age 580 years at the time of death (n = 37), or any case with missing pathological information or distinct non-Alzheimer's disease dementing syndrome (n = 31). Because the Nun Study was used as a validation cohort, also excluded were 211 cases missing detailed data about arteriolosclerosis severity. All exclusions were blind with regard to other aspects of pathological or clinical status (i.e. whether or not HS-Ageing pathology was present). Thus, 247 cases were included in the current study. The Nun Study data were not contributory to the NACC neuropathology data, and the arteriolosclerotic pathology was graded as a dichotomous (as opposed to four-level semi-quantitative) 'global' variable in this data set as to whether it was noted histopathologically in any brain region.
The NACC neuropathology data set contains information on neuropathological features and diagnoses for autopsied individuals who were evaluated at one of 34 different past and present Alzheimer's Disease Centres (ADCs) throughout the USA. This analysis includes subjects 80 years or older at death, who had been autopsied between January 2006 and December 2012. Before 2006, the diagnosis of hippocampal sclerosis pathology in the NACC neuropathology data set was infrequent (data not shown). Subjects were excluded from the NACC data analyses if they were evaluated at the UK-ADC; if they had missing pathological evaluation of neuritic plaque densities or Braak stages for neurofibrillary tangles; and if they had any of the unusual pathologies (e.g. prion disease) indicated above. From this validation cohort of 1631 cases, 187 cases were excluded because of lack of data about arteriolosclerosis pathology. Thus the final NACC cohort included 1444 autopsied cases.
Statistical analysis
Analyses were conducted separately on each cohort. Age at death is a potential confounder because advanced age increases the risk of HSAgeing pathology and is also associated with higher burden of cerebrovascular pathology (Nelson et al., 2011a, b) . Thus, in the UK-ADC cohort analyses, for which the most detailed data were available, three methods were used to control for the effect of age. Generalized linear regression was performed, with age at death used first as a covariate and then split into three categories [80-84 (28%) , 85-89 (34%) and 590 (38%)] and used as a factor. Finally, because there was poor overlap in the age distributions at the tails, an age-matched (exact matching on integer ages) nested case-control sample (n = 151, 39 cases and 112 controls) with two to three controls per case was selected for further study.
Potential UK-ADC group differences in infarct counts were compared with Poisson regression due to the preponderance of zero counts. Probability of HS-Ageing pathology present given semiquantitative measures of global atherosclerosis, arteriolosclerosis, and amyloid angiopathy was assessed with logistic regression. Logistic regression was also used to analyse a subset of the sample that had area-specific indications of the presence or absence of arteriolosclerosis.
Medical history data were also available on a subset of the sample, and logistic regression was used to estimate the odds ratio for cases with HS-Ageing versus controls separately for each condition. In the age-matched analyses, conditional regression was used to evaluate the data. Statistical significance for all comparisons was set at P 5 0.05. The family-wise type I error rate was set at 0.05, and the BonferroniHolm method was used to correct for multiple comparisons. Analyses were conducted via SAS 9.3 Õ .
Digital pathology
Because large autopsy cohort data indicated that arteriolosclerosis is associated with HS-Ageing pathology, but the operationalization of arteriolosclerosis is vague (see above), we performed digital pathological assessment of small blood vessels in human brain for more rigorous study of the specific small blood vessel morphological parameters that are associated with HS-Ageing pathology. Technical evaluations were performed using five different potential small blood vessel antibody markers: CD34 (QBEnd 10, Dako), -SMA (smooth muscle actin; 1A4, Dako), CD31 (JC70A, Dako), factor VIII (polyclonal, Dako), and collagen IV (CIV22, Cell Marque). The initial screen was to assess antibody robustness and appropriateness for banked tissue that had been fixed at various intervals in formalin before paraffin embedding. Adjacent 2-mm thick portions of frontal cortex (Brodmann area 9) were fixed in formalin for six different time intervals (1, 3, 7, 14, 30 , and 60 days), before paraffin embedding, sectioning, immunostaining, scanning on the Aperio ScanScope, and image analyses (see below for more details). Results provided support for using CD34 (a marker of capillaries) and -SMA (a marker of arterioles), as a result of a combination of strong staining intensity over a range of fixation times and excellent immunohistochemical signal to noise ratio (Supplementary Table 2 ). For detailed digital image analyses, a convenience sample of cases (n = 57) was selected as a representative subsample of the UK-ADC autopsy cohort. End-stage Alzheimer's disease (Braak stage VI) and FTLD cases were excluded because end-stage neurodegenerative pathology would be presumed to induce secondary vascular changes. Cases with neocortical -synucleinopathy also were excluded. The main criteria for case selection were a sampling of brains with and without HS-Ageing pathology, including distributions of Braak stages (0-5) and arteriolosclerosis severities (0-3) that were similar to the overall cohort (Supplementary Table 3 ). After the cases were selected, slides were cut from archived paraffin-embedded frontal cortex and stained with CD34 and -SMA antibodies. Both the CD34 and -SMA stained slides were then loaded onto the Aperio ScanScope XT and scanned at Â 40 magnification to create virtual slides, which were subsequently stored on a dedicated server. All pre-analytical steps were performed blind to pathological diagnosis, and no additional cases were included nor were any cases excluded after the initial case selection.
Image analyses were performed using the Aperio Microvessel Analysis algorithm, which was included with the Image Analysis Toolbox TM software. Modifications were made to the default algorithm parameters to adjust for background staining (Supplementary Table 4 Briefly, a 4 mm 2 box was placed within the grey matter in the region of highest pathology. Subsequent boxes were scattered through the remaining grey matter at maximum distances from each other to ensure an even distribution throughout the slide ( Supplementary Fig. 1 ). The same protocol was repeated for the white matter. Up to 10 boxes were placed in each cortical region (grey and white matter). The microvessel algorithm was subsequently run on these regions, in both the grey and white matter, for each case. The following parameters were calculated using the modified microvessel algorithm: number of vessels, total analysis area (mm 2 ), total stain area (mm 2 ), average stain intensity, microvessel density (vessels/mm 2 ), as well as mean (with standard deviation) and median vessel areas (mm 2 ), vessel perimeter (mm), lumen area (mm 2 ),vascular area (mm 2 ), and vessel wall thickness (mm). The resulting data were downloaded into spreadsheet format for assessment in Microsoft Excel. For digital pathological analyses, because we were testing the hypothesis that there is a greater burden of arteriolosclerosis in cases with HS-Ageing pathology, we used a one-tailed Student's t-test for between-group comparisons.
Results
A central goal of this study was to test whether cerebrovascular changes correlate specifically with HS-Ageing pathology. Previous work (Dickson et al., 1994; Jellinger, 1994; Nelson et al., 2011) led us to focus on pathological changes in small blood vessels, particularly arteriolosclerosis. Observations using haematoxylin and eosin stains to visualize disease-related pathology and blood vessel changes are shown in Figs 1 and 2. Figure 1 illustrates some of the hippocampal changes seen in HS-Ageing brains versus controls. Figure 2 shows blood vessel profiles at high magnification to illustrate the four-tier scoring system that was used for semi-quantitative assessment of arteriolosclerosis severity in the UK-ADC and NACC autopsy databases; in the Nun Study data, a dichotomous 'global' variable was used to indicate whether appreciable arteriolosclerosis was observed in those brains.
Association between hippocampal sclerosis of ageing pathology and arteriolosclerosis in large autopsy databases
The data from large autopsy series used in the current study represented different cohort types (Table 1) including the UK-ADC (convenience sample; n = 327 cases met inclusion criteria), the Nun Study (population-based sample; n = 247), and NACC (ADC multicentre sample; n = 1444). As shown in Table 2 , global arteriolosclerosis (which is a term used to denote a single semi-quantitative parameter of a given brain's arteriolosclerosis, incorporating all areas evaluated) was positively correlated with HS-Ageing pathology in both the Nun Study (P 5 0.04) and the statistically well-powered NACC autopsy data (P 5 0.0001). More detailed description of NACC data, stratifying for HS-Ageing and Alzheimer's disease pathology, is presented in Supplementary  Table 5 . For studies performed at UK-ADC, both sides of the brain were evaluated, but some centres among the NACC cohort evaluated only one side. We note that the age distribution in the Nun Study was right-shifted in the cases with HS-Ageing as was the case with the UK-ADC cohort, but we performed this analysis initially without age correction other than the inclusion of cases older than 80 years at death, and using a two-tailed P-value. When the Nun Study analysis was age-adjusted by logistic regression, then, depending on the specification for age, the one-tailed P-value for the correlation between HS-Ageing pathology and arteriolosclerosis is between 0.04 and 0.06 (data not shown). In secondary analyses of NACC data, neither history of hypertension nor diabetes was associated with HS-Ageing pathology (data not shown).
UK-ADC autopsy cohort cases, comprising highly detailed clinical and pathological data (including anatomical region-specific data), were the main focus in assessing the specificity of the association between HS-Ageing pathology and arteriolosclerosis.
Comparison groups were generated related to HS-Ageing pathology and were controlled for age at death through simple covariate adjustment and through age-matching, which makes no assumptions about the relationship (e.g. linear, quadratic) between age at death and neuropathological findings. The agematched groups, which were used for subsequent analyses in the UK-ADC cohort, are shown in Supplementary Table 6 . Both methods used to correct for age yielded similar results. There was no evidence that the distribution of the following cerebrovascular pathology subtypes was unequal between cases and controls: total infarcts, micro-infarcts, pale infarcts, lacunar infarcts, cortical laminar necrosis, circle of Willis atherosclerosis and cerebral amyloid angiopathy (CAA) ( Table 3, Supplementary Tables 7 and 8 ). Of the cerebrovascular pathology subtypes, arteriolosclerosis pathology was more severe in cases with HS-Ageing pathology than controls (P 5 0.03) although these data would not satisfy the correction for multiple comparisons (Table 3 and Supplementary  Tables 7 and 8 ). Unexpectedly, the rate of haemorrhagic infarction was lower in cases with HS-Ageing pathology in this sample (P $ 0.05), but again this P-value would not survive correction for multiple comparisons; we did not follow up this observation. Arteriolosclerosis has previously been correlated with cardiovascular co-morbidities such as hypertension and diabetes, so we sought to test the associations between known cardiovascular risk factors and HS-Ageing pathology. We assessed the associations between HS-Ageing pathology and the presence/absence of nine different risk factors including hypertension and type II diabetes in both the age-matched and unmatched for age casecontrol samples (Supplementary Tables 9-11 show similar results after different methods accounting for age). None of these risk factors were independently linked to HS-Ageing pathology in the UK-ADC cohort (95% confidence intervals all included 1.0) although we note limited sample size and potential bias because of missing data (Supplementary Table 1) .
In comparing UK-ADC cases with and without HS-Ageing pathology, we asked how anatomically widespread were the differences in arteriolosclerosis pathology. In many different brain regions, including neocortical and subcortical areas, arteriolosclerosis is more severe in cases with HS-Ageing pathology (Table 5 ). The exact arterial territories are not always possible to obtain when reviewing a microscope slide and thus are not included here. Notably, the hippocampal formation (CA1 and subiculum) was not among the areas where greater arteriolosclerosis was Hippocampal sclerosis of ageing pathology and small blood vessel morphology: digital pathology
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To further explore the strong link between HS-Ageing and arteriolosclerosis suggested by multiple large data sets, digital microvessel analyses were performed on sections of frontal cortex (Brodmann area 9); the goal was to identify characteristics that would separate cases with and without HS-Ageing pathology. The cases used for digital pathology incorporated a representative spectrum of Alzheimer's disease pathology, arteriolosclerosis severity, hypertension, diabetes, and apolipoprotein E (APOE) alleles, with and without HS-Ageing pathology (Supplementary Table 3 ). Representative results of immunostaining blood vessels in human neocortex are shown in Fig. 3 (lower-power photomicrographs are provided in Supplementary Fig. 2 ), and our process for deciding which immunostains to use in our digital pathological analyses is shown in Fig. 4 . From the convenience sample (n = 57 different cases) used for detailed digital pathological analyses, which included 15 cases with (Table 6 ; P 5 0.05 for each of these comparisons using one-tailed Student's t-test). In addition, cases with HS-Ageing showed significantly thicker vessel walls (mean thickness 1.817 mm versus 1.731 mm) within the grey matter. Figure 5 shows data derived from analyses of grey matter, stratifying on HS-Ageing and Alzheimer's disease pathologies. While not necessarily reaching statistical significance with the other variables, cases with HS-Ageing pathology show a trend for higher values in nearly all the other vascular size parameters in the larger vessels identified by -SMA, illustrated by the ratio of HS-Ageing/non-HS-Ageing cases shown (Table 5) . Differences in blood vessel morphology between cases and controls were less apparent in white matter than grey matter. In the white matter, only the median -SMA vessel perimeter remained significantly larger in the cases with HS-Ageing pathology (79.0 mm versus 74.3 mm) (Fig. 6 and Table 6 ). The changes linked to HS-Ageing pathology were at least somewhat diseasespecific since there was a lack of group-level differences in these parameters according to Alzheimer's disease pathological status. Cases with Alzheimer's disease tended to have slightly higher density of grey matter -SMA-immunoreactive blood vessels in comparison with non-Alzheimer's disease cases (data not shown). However, the Alzheimer's disease pathology-based comparisons indicate that the blood vessel perimeter changes in cases with HS-Ageing pathology are not merely a non-specific change related to neurodegeneration. No significant differences were noted with the CD34-immunopositive vascular profiles stratifying by HS-Ageing pathological status; the blood vessel morphological changes in cases with HS-Ageing are preferentially within the -SMA-immunoreactive arterioles. The observation of thicker arterioles in the frontal cortex of cases with HS-Ageing pathology, but not Alzheimer's disease pathology, is compatible with the semi-quantitative data analysed from large autopsy series above, indicating that arteriolosclerosis is linked to HS-Ageing pathology (Fig. 7) . The pictures on the right denote the mark-up generated by the microvessel analysis algorithms, tailored to each individual stain. Actual immunohistochemical stain is brown (A, C, E, G and I) whereas the digital detection of those markers is false-coloured green (B, D, F, H and J) after digital analyses were run. This is the basis for further in silico analyses of the blood vessel morphology. Scale bars = 25 mm.
Frontal Cortex (Brodmann area 9) Figure 4 Process for characterization and optimization of immunohistochemistry and digital pathology. The flowchart shows immunohistochemical markers that were assessed initially to optimize technical properties suitable for digital pathological analyses of small blood vessels, along with the criteria that were applied to choose the markers to be included in, or excluded from, additional digital pathological studies.
Selected for digital analysis

Discussion
Data from multiple large autopsy series were analysed to study cerebrovascular pathological parameters in patients with HSAgeing pathology. These studies incorporated 4200 subjects with autopsy-proven HS-Ageing pathology and $2000 controls. We found no definitive link between cardiac risk factors (including hypertension and diabetes) and HS-Ageing pathology. Brains with HS-Ageing pathology also tend to have arteriolosclerosis in multiple cortical and subcortical regions. We report for the first time digital pathological quantification of geometric properties of small human brain blood vessels using CD34 and -SMA immunohistochemistry, coupled with digital scanning and software-based image recognition, which increased the quantitative rigor of our study. These observations and analyses indicate that there is a relatively specific association between HS-Ageing and arteriolosclerosis pathologies.
There are potential limitations inherent to these analyses. The retrospective assessment of pathological data from large autopsy series entails potential sources of bias despite the large sample sizes and rigorous pathological assessments. For example, recent years have seen an increase in recognition of the impact and importance of HS-Ageing, so neuropathologists' tendency to arrive at that diagnosis may have increased. We also note that the existing definitions used to delineate the severity of arteriolosclerosis (described in the 'Materials and methods' section above) are vague, and thus may vary according to many factors. However, we do not know of a specific source of systematic bias that would cause the HS-Ageing and arteriolosclerosis pathologies to be spuriously correlated with each other. Note that for two of the autopsy series used in the current study (UK-ADC and the Nun Study, the latter of which used cases that had been evaluated before 2010), all of the pathological analyses were performed at the same site, the University of Kentucky. Another issue with regard to the retrospective analyses of autopsy series is missing data, which is a concern even in cohorts such as the UK-ADC where clinical data are relatively complete. However, it is not obvious how the correlation between HS-Ageing pathology and arteriolosclerosis would be because of missing data alone. A final caveat is that there are not universally applied rubrics for pathological diagnoses of either HS-Ageing or arteriolosclerosis. A recent study (Rauramaa et al., 2013) described guidelines for pathological description of hippocampal pathology including hippocampal sclerosis but most of these patients were younger than 80 at death. The lack of standardized and universally applied diagnostic rules for HS-Ageing is directly relevant to the current study because only about half of cases noted to have HS-Ageing pathology were also found to have arteriolosclerosis pathology. As neuropathologists are not necessarily sensitized to low-severity arteriolosclerosis, a higher actual proportion of cases with HS-Ageing may have arteriolosclerosis than the current analyses would indicate. We also note that among other strong, proven risk factors for neurodegenerative diseases, APOE accounts for less than half of cases with Alzheimer's disease, and progranulin (GRN) mutations cause less than half of FTLD cases.
Previous studies have provided support for the hypothesis that HS-Ageing pathological changes in the hippocampus are just one component of a brain-wide pathological process (Dickson et al., 1994; Nelson et al., 2011; Zarow et al., 2012) . Of most relevance to the current study, Dickson and colleagues (1994) noted in a seminal autopsy study that 12 of 13 evaluated cases with hippocampal sclerosis demonstrated pathologically-confirmed arteriolosclerosis (Dickson et al., 1994) . Using multiple data sets and digital pathology, we here confirm the strong association between arteriolosclerosis and HS-Ageing pathologies. We also added new observations: the association is surprisingly specific to arteriolosclerosis and is neither associated with other cerebrovascular pathology subtypes nor with known clinical cardiovascular risk factors. Furthermore, the arteriolosclerosis changes localize to -SMAimmunoreactive arterioles rather than CD34-immunoreactive capillaries, and particularly grey matter vessels, and these changes were not seen in Alzheimer's disease brains.
The strong association between arteriolosclerosis and HS-Ageing pathologies provides the basis for hypotheses about HS-Ageing pathogenesis (Fig. 7) and also raises at least three key questions. First, what else, besides HS-Ageing, is associated pathogenetically with arteriolosclerosis? Second, is there a specific link between arteriolosclerosis and the previously described molecular pathological correlate of HS-Ageing, namely aberrant TDP-43 immunoreactivity? And finally, why don't other subtypes of cerebrovascular pathology correlate with HS-Ageing?
Much is still unknown about both arteriolosclerosis and HSAgeing pathologies. There is a widely recognized link between hypertension and arteriolosclerosis in the brain and other organs (Dozono et al., 1991; Venkatachalam et al., 2010; Kanbay et al., 2011) . However, we found that the strength of the association between hypertension and arteriolosclerosis is considerably weaker than the association between arteriolosclerosis and HS-Ageing pathology. This may be partly due to imperfect pre-mortem data. Future studies may discover that there is indeed a stronger link between hypertension or other systemic factors (for example, diabetes) and HS-Ageing pathology than we could find evidence for in these cohorts. A contrasting hypothesis is that constitutional factors in the blood vessel walls themselves are directly linked to arteriolosclerosis and thus to HS-Ageing. There have previously been observations of aged humans' cortical blood vessels, including vessel wall 'tortuosity' and collagenosis (Brown et al., 2002 (Brown et al., , 2009 Farkas et al., 2006; Thore et al., 2007) . We note that some previous studies of arteriolar tortuosity focused on white matter blood vessels, using thicker sections, whereas our digital pathological methods find arteriolar changes in both grey and white matter ( These observations are compatible with at least four separate mechanistic hypotheses. First, systemic factors such as hypertension independently may contribute to HS-Ageing (blue arrow) and if this were true the correlation with arteriolosclerosis may be coincidental. We found no evidence for this hypothesis. Second, unknown systemic factors may cause arteriolosclerosis which independently itself contributes to HS-Ageing pathology (yellow arrows). Third, as-yet uncharacterized factors in small blood vessels could more directly contribute to and/or manifest as both arteriolosclerosis and HS-Ageing (dark pink arrows). Fourth, HSAgeing pathology may promote arteriolosclerosis (light pink arrows). Future studies are required to test these hypotheses. Thore, 2011) . We did not perform a comprehensive study of blood vessel morphology related to Alzheimer's disease pathology, as previous studies have focused on that area (Thal et al., 2003; Bouras et al., 2006; Hunter et al., 2012) . As the cases with mildmoderate arteriolosclerosis seem to be at increased risk of HS-Ageing in the larger NACC sample, this may indicate a specific risk factor that is different from what causes severe arteriolosclerosis. It is difficult to assess the physiological impact of the blood vessel changes we observe in terms of haemodynamics or metabolic impact. Unfortunately, there is still incomplete comprehension of how arteriolosclerosis impacts the brain or how the cells of the blood vessel wall contribute to arteriolosclerosis vulnerability.
If arteriolosclerosis is pathogenetically linked with HS-Ageing, then there may also be a connection with TDP-43 molecular pathology because the large majority of cases with HS-Ageing show aberrant TDP-43 immunoreactivity (Amador-Ortiz et al., 2007; Nelson et al., 2011) . By contrast, neither acute hypoxia nor epilepsy-linked causes of hippocampal injury induce TDP-43 pathology (Lee et al., 2008; Nelson et al., 2011) despite causing a pathological picture that may also be referred to as 'hippocampal sclerosis'. We previously described the lack of correlation between large-vessel cerebrovascular pathology and HS-Ageing, and described how it is important to perform the correlation mindful of the fact that cerebrovascular pathology and HS-Ageing are both highly prevalent in older individuals' brains (Nelson et al., 2011) . Together these observations indicate that HS-Ageing pathology is not simply a response to ischaemic-reperfusion injury to the brain. Aberrant TDP-43 immunoreactivity also is seen in FTLD in association with mutations in GRN (Baker et al., 2006; Ahmed et al., 2007) , in kindreds bearing mutations in some other FTLDand amyotrophic lateral sclerosis-linked genes (Van Langenhove et al., 2012) , and in some cases of chronic traumatic encephalopathy (McKee et al., 2010; Saing et al., 2011) . As the gene product of GRN, the progranulin protein, is thought to play a physiological role in wound repair and inflammation (Eriksen and Mackenzie, 2008) , there might be a mechanistic link between chronic mechanical injury and TDP-43 pathology, with arteriolosclerosis contributing to (or manifesting in parallel with the neuronal pathology as a result of common upstream stimuli causing) TDP-43 pathology.
From a technical standpoint, the digital pathology image analysis evaluation provided a key added dimension to our study because we could analyse multiple geometric properties of many thousands of small blood vessels in a relatively unbiased manner. This method offers more quantitative and robust data than most previous methods for small blood vessel analyses. Rather than only finding that 'arteriolosclerosis' is increased in HS-Ageing, we could reach more biologically-informative conclusions: -SMA-immunoreactive small blood vessels (presumably comprising mostly arterioles) have thicker walls, larger perimeter, and larger lumen size, whereas smaller CD-34 immunoreactive profiles (mostly capillaries) are not significantly altered in HS-Ageing versus controls. These observations fit with previous work focusing on digital pathological analyses of Alzheimer's disease neuropathology (Armstrong and Cairns, 2009; Murray et al., 2011; Robinson et al., 2011; Neltner et al., 2012) , and indicate that digital pathological evaluations do indeed provide an added dimension for neuropathological investigations, enabling us to surmount some of the human eye's limitations.
Overall, arteriolosclerosis is positively correlated with HS-Ageing pathology, and that relationship seems specific because neither other cerebrovascular pathological subtypes nor cardiovascular risk factors are strongly correlated with HS-Ageing pathology. Arteriolosclerosis was also not correlated with Alzheimer's disease pathology. The pathways and processes that cause dysfunction of brain arterioles in HS-Ageing are still unknown. These data add to an evolving appreciation that HS-Ageing is a whole-brain disease, although hippocampal neurodegeneration is currently the defining manifestation.
